Adam Koppel

Insider Reports History

Entity
Individual
Location
C/O Brookside Capital, Llc, John Hancock Tower, 200 Clarendon St, Boston, MA
Signature
/s/ Adam Koppel
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Adam Koppel:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Solid Biosciences Inc. Director, 10%+ Owner Common Stock 4.03M $22.3M $5.53 Jan 11, 2024 Indirect
Foghorn Therapeutics Inc. Director Stock Options (Right to buy) 16K $88.3K $5.52 Jun 26, 2024 Direct
Cerevel Therapeutics Holdings, Inc. Director, 10%+ Owner Common Stock 0 $0 $41.18 Aug 1, 2024 Direct
Cerevel Therapeutics Holdings, Inc. Director, 10%+ Owner Common Stock 0 $0 $41.18 Aug 1, 2024 Indirect
Aptinyx Inc. Director, 10%+ Owner Stock Option (Right to Buy) 40K May 26, 2022 Direct
Solid Biosciences Inc. Director, 10%+ Owner Director Stock Option (Right to Buy) 9.65K Jun 6, 2023 Direct
Cerevel Therapeutics Holdings, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 0 Aug 1, 2024 Direct
Dicerna Pharmaceuticals Inc Director Common Stock 0 $38.25 Dec 28, 2021 Direct
Dicerna Pharmaceuticals Inc Director Common Stock 0 $38.25 Dec 28, 2021 Indirect
Dicerna Pharmaceuticals Inc Director Director Stock Option (Right to Buy) 0 Dec 28, 2021 Direct
Dicerna Pharmaceuticals Inc Director Restricted Stock Units 0 Dec 28, 2021 Direct

Insider Reports Filed by Adam Koppel

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CERE Cerevel Therapeutics Holdings, Inc. Aug 1, 2024 4 $0 4 Aug 5, 2024 Director, 10%+ Owner
FHTX Foghorn Therapeutics Inc. Jun 26, 2024 1 $88.3K 4 Jun 28, 2024 Director
CERE Cerevel Therapeutics Holdings, Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director, 10%+ Owner
SLDB Solid Biosciences Inc. Jan 11, 2024 1 $5M 4 Jan 12, 2024 Director, 10%+ Owner
CERE Cerevel Therapeutics Holdings, Inc. Oct 16, 2023 1 $125M 4 Oct 18, 2023 Director, 10%+ Owner
FHTX Foghorn Therapeutics Inc. Jun 21, 2023 1 $0 4 Jun 22, 2023 Director
CERE Cerevel Therapeutics Holdings, Inc. Jun 7, 2023 3 $0 4 Jun 9, 2023 Director, 10%+ Owner
SLDB Solid Biosciences Inc. Jun 6, 2023 1 $0 4 Jun 8, 2023 Director, 10%+ Owner
SLDB Solid Biosciences Inc. Dec 13, 2022 1 $0 4 Dec 15, 2022 Director, 10%+ Owner
SLDB Solid Biosciences Inc. Dec 2, 2022 1 $0 4 Dec 5, 2022 Director, 10%+ Owner
SLDB Solid Biosciences Inc. Dec 2, 2022 0 $0 3 Dec 5, 2022 Director, 10%+ Owner
FHTX Foghorn Therapeutics Inc. Jun 21, 2022 1 $0 4 Jun 22, 2022 Director
CERE Cerevel Therapeutics Holdings, Inc. Jun 14, 2022 1 $0 4 Jun 16, 2022 Director, 10%+ Owner
APTX Aptinyx Inc. May 26, 2022 1 $0 4 May 31, 2022 Director, 10%+ Owner
DRNA Dicerna Pharmaceuticals Inc Dec 28, 2021 9 -$118M 4 Dec 29, 2021 Director
FHTX Foghorn Therapeutics Inc. Jul 13, 2021 1 $0 4 Jul 14, 2021 Director
SLDB Solid Biosciences Inc. Jun 16, 2021 1 $0 4 Jun 21, 2021 Director
CERE Cerevel Therapeutics Holdings, Inc. Jun 10, 2021 1 $0 4 Jun 14, 2021 Director, 10%+ Owner
DRNA Dicerna Pharmaceuticals Inc Jun 3, 2021 4 $0 4 Jun 7, 2021 Director
APTX Aptinyx Inc. May 27, 2021 1 $0 4 Jun 1, 2021 Director, 10%+ Owner